Achieve Life Sciences, Inc (ACHV) insider trading

Every open-market stock purchase and sale by Achieve Life Sciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Mark K Oki (CFO), $28.9K, 19 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $5.75 on Jun 10, 2026.

Recent ACHV insider trades

DateInsiderTradeValue
May 29, 2026Reid Alexander Waldman (Insider)Bought (not open market)—
May 29, 2026Jeffrey S Farrow (Insider)Bought (not open market)—
May 11, 2026Christopher Nathan Martin (Insider)Bought (not open market)—
Apr 18, 2026Andrew D. Goldberg (CEO)Bought (not open market)—
Apr 18, 2026Andrew D. Goldberg (CEO)Bought (not open market)—
Apr 18, 2026Andrew D. Goldberg (CEO)Bought (not open market)—
Jan 28, 2026Richard Alistair Stewart (CEO)Bought (not open market)—
Jan 28, 2026Mark Lawrence Rubinstein (C-suite exec)Bought (not open market)—
Jan 28, 2026Craig Donnelly (C-suite exec)Bought (not open market)—
Jan 28, 2026Mark K Oki (CFO)Bought (not open market)—
Jan 28, 2026Jaime Xinos (C-suite exec)Bought (not open market)—
Jan 28, 2026Jerry Wan (Insider)Bought (not open market)—
Dec 4, 2025Erik Atkisson (C-suite exec)Bought (not open market)—

Who's trading ACHV

Get free alerts when an insider at Achieve Life Sciences, Inc files a new trade →